{"id":47213,"date":"2022-06-03T11:00:17","date_gmt":"2022-06-03T02:00:17","guid":{"rendered":"https:\/\/www.veeva.com\/jp\/?p=47213"},"modified":"2022-06-13T16:22:02","modified_gmt":"2022-06-13T07:22:02","slug":"veeva-vault-ctms-enabling-proactive-clinical-trial-management-for-more-than-150-companies","status":"publish","type":"post","link":"https:\/\/pantheon.veeva.com\/jp\/news\/veeva-vault-ctms-enabling-proactive-clinical-trial-management-for-more-than-150-companies\/","title":{"rendered":"Veeva Vault CTMS\u306b\u3088\u308a150\u793e\u4ee5\u4e0a\u306e\u4f01\u696d\u304c\u30d7\u30ed\u30a2\u30af\u30c6\u30a3\u30d6\u306a\u81e8\u5e8a\u8a66\u9a13\u7ba1\u7406\u3092\u5b9f\u73fe"},"content":{"rendered":"<p style=\"text-align: center;\">\uff5e Vault CTMS\u306e\u65b0\u305f\u306a\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u306b\u3088\u308a\u3001<\/p>\n<p style=\"text-align: center;\">\u696d\u754c\u5168\u4f53\u3067\u81e8\u5e8a\u8a66\u9a13\u306e\u30ef\u30fc\u30af\u30d5\u30ed\u30fc\u304c\u30b9\u30ea\u30e0\u5316\u3055\u308c\u3001\u8a66\u9a13\u5b9f\u65bd\u3092\u8fc5\u901f\u5316 \uff5e<\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: right;\">2022\u5e746\u67083\u65e5<\/p>\n<p style=\"text-align: right;\">Veeva Japan\u682a\u5f0f\u4f1a\u793e<\/p>\n<p>&nbsp;<\/p>\n<p>Veeva Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : Sebastian Bather\u3001\u4ee5\u4e0b Veeva) \u306f\u3001150\u793e\u4ee5\u4e0a\u306e\u30b0\u30ed\u30fc\u30d0\u30eb\u4f01\u696d\u3084\u6025\u6210\u9577\u4e2d\u306e\u4f01\u696d\u304c<strong><a href=\"https:\/\/www.veeva.com\/jp\/products\/vault-ctms\/\">Veeva Vault CTMS<\/a><\/strong>\u3092\u5229\u7528\u3057\u3066\u3001\u30af\u30ea\u30cb\u30ab\u30eb\u30aa\u30da\u30ec\u30fc\u30b7\u30e7\u30f3\u3092\u63a8\u9032\u3057\u3066\u3044\u308b\u3053\u3068\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002\u30b9\u30dd\u30f3\u30b5\u30fc\u3068\u533b\u85ac\u54c1\u958b\u767a\u696d\u52d9\u53d7\u8a17\u6a5f\u95a2\uff08CRO\uff09\u306fVault CTMS\u3092\u4f7f\u7528\u3057\u306630\u4e07\u4ee5\u4e0a\u306e\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u3068\u9023\u643a\u3057\u3001\u3042\u3089\u3086\u308b\u8a66\u9a13\u30d5\u30a7\u30fc\u30ba\u306b\u3042\u308b100\u4e07\u4eba\u4ee5\u4e0a\u306e\u60a3\u8005\u3092\u30b5\u30dd\u30fc\u30c8\u3057\u3066\u3044\u307e\u3059\u3002Vault CTMS\u306e\u5c0e\u5165\u62e1\u5927\u306b\u3088\u308a\u3001\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u306f\u30d7\u30ed\u30a2\u30af\u30c6\u30a3\u30d6\u306b\u81e8\u5e8a\u8a66\u9a13\u3092\u7ba1\u7406\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308a\u3001\u3088\u308a\u9023\u643a\u6027\u306e\u9ad8\u3044\u30c7\u30b8\u30bf\u30eb\u306a\u672a\u6765\u306b\u5411\u3051\u3066\u52a0\u901f\u3057\u3066\u3044\u307e\u3059\u3002 (\u672c\u30ea\u30ea\u30fc\u30b9\u306f\u3001Veeva\u7c73\u56fd\u672c\u793e\u304c\u767a\u8868\u3057\u305f\u5831\u9053\u8cc7\u6599\u306e\u6284\u8a33\u3067\u3059\u3002\u539f\u6587\u306f<strong><a href=\"https:\/\/www.veeva.com\/resources\/veeva-vault-ctms-enabling-proactive-clinical-trial-management-for-more-than-150-companies\/\">\u3053\u3061\u3089<\/a><\/strong>\u304b\u3089\u304a\u8aad\u307f\u3044\u305f\u3060\u3051\u307e\u3059\u3002)<\/p>\n<p>&nbsp;<\/p>\n<p>Veeva\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3051\u308b\u91cd\u8981\u306a\u8ab2\u984c\u3092\u89e3\u6c7a\u3059\u308b\u305f\u3081\u306e\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u3092\u63d0\u4f9b\u3057\u7d9a\u3051\u3066\u3044\u307e\u3059\u3002\u4f8b\u3048\u3070\u3001\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u306e\u30e2\u30cb\u30bf\u30ea\u30f3\u30b0\u306b\u95a2\u3057\u3001Vault CTMS\u3092\u5229\u7528\u3057\u3066\u3044\u308b\u304a\u5ba2\u69d8\u306f\u3001\u81ea\u52d5\u5316\u3068\u30ea\u30a2\u30eb\u30bf\u30a4\u30e0\u306e\u60c5\u5831\u5171\u6709\u306b\u3088\u308a\u3001\u65bd\u8a2d\u8a2a\u554f\u5831\u544a\u66f8\u306e\u4f5c\u6210\u3068\u63d0\u51fa\u306b\u304b\u304b\u308b\u65e5\u6570\u3092465\u65e5\u4ee5\u4e0a\u77ed\u7e2e\u3067\u304d\u307e\u3059\u3002\u751f\u7523\u6027\u306e\u5411\u4e0a\u306b\u52a0\u3048\u3001Vault CTMS\u3092\u5c0e\u5165\u3057\u305f\u30b9\u30dd\u30f3\u30b5\u30fc\u3084CRO\u306f\u30c7\u30fc\u30bf\u54c1\u8cea\u3092\u5411\u4e0a\u3067\u304d\u3001\u3088\u308a\u7684\u78ba\u306a\u60c5\u5831\u306b\u57fa\u3065\u3044\u305f\u610f\u601d\u6c7a\u5b9a\u3092\u884c\u3044\u3001\u81e8\u5e8a\u8a66\u9a13\u3092\u8a08\u753b\u901a\u308a\u306b\u5b9f\u65bd\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308a\u307e\u3059\u3002<\/p>\n<p>\u6bce\u5e743\u56de\u306e\u88fd\u54c1\u3092\u30ea\u30ea\u30fc\u30b9\u3057\u3066\u3044\u308bVeeva\u306f\u3001\u4e3b\u8981\u306a\u81e8\u5e8a\u8a66\u9a13\u30d7\u30ed\u30bb\u30b9\u306e\u6700\u65b0\u5316\u3092\u9032\u3081\u308b\u3053\u3068\u3067\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u30b9\u30d4\u30fc\u30c9\u30a2\u30c3\u30d7\u3092\u652f\u63f4\u3057\u3066\u3044\u307e\u3059\u3002Vault CTMS\u306b\u306f\u6b21\u306e\u65b0\u6a5f\u80fd\u304c\u542b\u307e\u308c\u307e\u3059\u3002<\/p>\n<ul>\n<li><a href=\"https:\/\/www.veeva.com\/jp\/resources\/vault-ctms-risk-based-study-management-product-brief\/\"><strong>\u30ea\u30b9\u30af\u30d9\u30fc\u30b9\u306e\u30b9\u30bf\u30c7\u30a3\u30de\u30cd\u30b8\u30e1\u30f3\u30c8<\/strong><\/a>\u6a5f\u80fd\u306b\u3088\u308a\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u30ea\u30b9\u30af\u3092\u30b7\u30fc\u30e0\u30ec\u30b9\u306b\u8a55\u4fa1\u3057\u3066\u8efd\u6e1b<\/li>\n<li>\u65bd\u8a2d\u8a2a\u554f\u5831\u544a\u66f8\u306e\u30d0\u30fc\u30b8\u30e7\u30f3\u7ba1\u7406\u3084\u30ef\u30f3\u30af\u30ea\u30c3\u30af\u8cea\u554f\u306a\u3069\u306e\u6a5f\u80fd\u306b\u3088\u308a\u3001\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u306e\u30e2\u30cb\u30bf\u30ea\u30f3\u30b0\u3092\u5f37\u5316\u3057\u3066\u8a66\u9a13\u306e\u5b9f\u65bd\u3092\u8fc5\u901f\u5316<\/li>\n<li><strong><a href=\"https:\/\/www.veeva.com\/jp\/CTMS-oversight\/\">\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3051\u308b\u30aa\u30fc\u30d0\u30fc\u30b5\u30a4\u30c8<\/a><\/strong>\u6a5f\u80fd\u306b\u3088\u308a\u3001\u3055\u307e\u3056\u307e\u306a\u554f\u984c\u3084\u30d7\u30ed\u30c8\u30b3\u30eb\u9038\u8131\u306e\u7ba1\u7406\u3092\u5bb9\u6613\u306b\u3057\u3066\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u3092\u5411\u4e0a<\/li>\n<\/ul>\n<p>Veeva Vault CTMS\u62c5\u5f53\u30f4\u30a1\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u306eHenry Galio\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300cVeeva\u306f\u3001\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u304c\u30af\u30ea\u30cb\u30ab\u30eb\u30aa\u30da\u30ec\u30fc\u30b7\u30e7\u30f3\u3092\u6539\u5584\u3057\u3001\u60a3\u8005\u69d8\u306b\u533b\u85ac\u54c1\u3092\u3088\u308a\u8fc5\u901f\u306b\u5c4a\u3051\u308b\u3053\u3068\u304c\u3067\u304d\u308b\u3088\u3046\u3001\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u3092\u63d0\u4f9b\u3057\u7d9a\u3051\u3066\u3044\u307e\u3059\u3002\u63d0\u4f9b\u958b\u59cb\u304b\u3089\u308f\u305a\u304b5\u5e74\u3067\u3001150\u793e\u4ee5\u4e0a\u306e\u4f01\u696d\u304cVeeva Vault CTMS\u3092\u5c0e\u5165\u3057\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u30ea\u30b9\u30af\u7ba1\u7406\u3084\u65bd\u8a2d\u8a2a\u554f\u5831\u544a\u66f8\u306e\u30e2\u30cb\u30bf\u30ea\u30f3\u30b0\u306a\u3069\u306e\u8907\u96d1\u306a\u81e8\u5e8a\u8a66\u9a13\u30d7\u30ed\u30bb\u30b9\u3092\u5927\u5e45\u306b\u30b9\u30ea\u30e0\u5316\u3057\u3066\u3044\u307e\u3059\u3002\u79c1\u305f\u3061\u306f\u3053\u306e\u696d\u754c\u3092\u30b5\u30dd\u30fc\u30c8\u3067\u304d\u308b\u3053\u3068\u3092\u8a87\u308a\u306b\u601d\u3063\u3066\u304a\u308a\u3001\u4eca\u5f8c\u3082\u304a\u5ba2\u69d8\u3068\u5354\u529b\u3057\u306a\u304c\u3089\u30c7\u30b8\u30bf\u30eb\u81e8\u5e8a\u8a66\u9a13\u306e\u30b9\u30d4\u30fc\u30c9\u30a2\u30c3\u30d7\u3068\u30b3\u30b9\u30c8\u52b9\u7387\u306e\u5411\u4e0a\u3092\u76ee\u6307\u3057\u3066\u3044\u304d\u307e\u3059\u3002\u300d<\/p>\n<p>\u88fd\u85ac\u4f01\u696d\u4e0a\u4f4d20\u793e\u306e\u3046\u306110\u793e\u3001CRO\u4e0a\u4f4d6\u793e\u306e\u3046\u30613\u793e\u3092\u542b\u3080\u591a\u304f\u306e\u4f01\u696d\u304c\u3001\u81e8\u5e8a\u8a66\u9a13\u30aa\u30da\u30ec\u30fc\u30b7\u30e7\u30f3\u306e\u30b9\u30ea\u30e0\u5316\u306e\u305f\u3081\u306bVault CTMS\u3092\u5229\u7528\u3057\u3066\u304a\u308a\u3001\u305d\u306e\u6570\u306f\u4eca\u3082\u5897\u3048\u7d9a\u3051\u3066\u3044\u307e\u3059\u3002Vault CTMS\u306f\u3001<strong><a href=\"https:\/\/www.veeva.com\/jp\/products\/clinical-operations\/\">Veeva\u00a0Vault Clinical Operations Suite<\/a><\/strong>\u306e\u4e00\u90e8\u3067\u3059\u3002CTMS\u3001eTMF\u3001study start-up\u3001\u652f\u6255\u3044\u306a\u3069\u306b\u95a2\u3059\u308b\u60c5\u5831\u3084\u30c9\u30ad\u30e5\u30e1\u30f3\u30c8\u306e\u5171\u6709\u3092\u652f\u63f4\u3057\u3001\u8a66\u9a13\u306e\u30e9\u30a4\u30d5\u30b5\u30a4\u30af\u30eb\u5168\u4f53\u3092\u901a\u3057\u3066\u30b3\u30e9\u30dc\u30ec\u30fc\u30b7\u30e7\u30f3\u3068\u52b9\u7387\u6027\u306e\u5411\u4e0a\u3092\u5b9f\u73fe\u3057\u307e\u3059\u3002<\/p>\n<p><strong><a href=\"https:\/\/www.veeva.com\/eu\/events\/rd-summit\/?\">Veeva R&amp;D and Quality Summit Europe<\/a><\/strong>\u3067\u306f\u3001\u4f01\u696d\u5404\u793e\u304c\u3069\u306e\u3088\u3046\u306bVault CTMS\u3092\u5229\u7528\u3057\u3066\u3001\u30d7\u30ed\u30bb\u30b9\u3092\u8fc5\u901f\u5316\u3057\u3066\u3044\u308b\u306e\u304b\u3054\u7d39\u4ecb\u3057\u307e\u3059\u3002\u3053\u306e\u30a4\u30d9\u30f3\u30c8\u306f\u3001\u73fe\u5730\u53c2\u52a0\u578b\u30676\u67088\u65e5\u306b\u30c1\u30e5\u30fc\u30ea\u30c3\u30d2\u3067\u958b\u50ac\u3055\u308c\u308b\u3001\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u696d\u754c\u306e\u30d7\u30ed\u30d5\u30a7\u30c3\u30b7\u30e7\u30ca\u30eb\u9650\u5b9a\u306e\u30a4\u30d9\u30f3\u30c8\u3067\u3059\u3002\u8a73\u7d30\u3068\u53c2\u52a0\u767b\u9332\u306f<strong><a href=\"https:\/\/www.veeva.com\/eu\/events\/rd-summit\/inperson-registration\/\">veeva.com\/jp\/euSummit<\/a><\/strong>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n<p>&nbsp;<\/p>\n<p><strong>\u3010<\/strong><strong>Veeva Systems<\/strong><strong>\u793e\u306b\u3064\u3044\u3066\u3011<\/strong><br \/>\nVeeva Systems\u793e\u306f\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u5411\u3051\u306b\u30af\u30e9\u30a6\u30c9\u30d9\u30fc\u30b9\u306e\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u3092\u63d0\u4f9b\u3059\u308b\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30ab\u30f3\u30d1\u30cb\u30fc\u3067\u3059\u3002\u4e16\u754c\u6700\u5927\u898f\u6a21\u306e\u88fd\u85ac\u4f1a\u793e\u304b\u3089\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u5206\u91ce\u306e\u65b0\u8208\u4f01\u696d\u307e\u30671,100\u793e\u3092\u8d85\u3048\u308b\u9867\u5ba2\u306b\u3001\u6280\u8853\u9769\u65b0\u3078\u306e\u53d6\u308a\u7d44\u307f\u3084\u5353\u8d8a\u3057\u305f\u88fd\u54c1\u529b\u306b\u3088\u3063\u3066\u3001\u304a\u5ba2\u69d8\u306e\u6210\u529f\u306b\u30b3\u30df\u30c3\u30c8\u3059\u308b\u69d8\u3005\u306a\u30b5\u30fc\u30d3\u30b9\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002\u30d1\u30d6\u30ea\u30c3\u30af\u30fb\u30d9\u30cd\u30d5\u30a3\u30c3\u30c8\u30fb\u30b3\u30fc\u30dd\u30ec\u30fc\u30b7\u30e7\u30f3\u4f01\u696d\u3068\u3057\u3066Veeva\u306f\u3001\u9867\u5ba2\u3084\u5f93\u696d\u54e1\u3001\u63d0\u643a\u4f01\u696d\u3001\u682a\u4e3b\u3001\u30b5\u30fc\u30d3\u30b9\u63d0\u4f9b\u696d\u754c\u3092\u542b\u3080\u3059\u3079\u3066\u306e\u30b9\u30c6\u30fc\u30af\u30db\u30eb\u30c0\u30fc\u306e\u5229\u76ca\u30d0\u30e9\u30f3\u30b9\u3092\u4fdd\u3064\u3053\u3068\u306b\u30b3\u30df\u30c3\u30c8\u3057\u307e\u3059\u3002\u8a73\u3057\u304f\u306f\u3001<a href=\"https:\/\/www.veeva.com\/jp\/\">veeva.com\/jp<\/a>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n<p><strong>\u3010Forward-looking Statements<\/strong><strong>\u3011<\/strong><br \/>\nThis release contains forward-looking statements regarding Veeva\u2019s products and services and the expected results or benefits from use of our products and services. Such statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-K for the period ended January 31, 2022, which you can find <a href=\"https:\/\/www.sec.gov\/ix?doc=\/Archives\/edgar\/data\/1393052\/000139305221000040\/veev-20211031.htm\">here<\/a> (a summary of risks which may impact our business can be found on pages 13 and 14), and in our subsequent SEC filings, which you can access at <a href=\"http:\/\/sec.gov\/\">sec.gov<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u30b9\u30dd\u30f3\u30b5\u30fc\u3068\u533b\u85ac\u54c1\u958b\u767a\u696d\u52d9\u53d7\u8a17\u6a5f\u95a2\uff08CRO\uff09\u306f\u3001Veeva Vault CTMS\u3092\u4f7f\u7528\u3057\u306630\u4e07\u4ee5\u4e0a\u306e\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u3068\u9023\u643a\u3057\u3001\u3042\u3089\u3086\u308b\u8a66\u9a13\u30d5\u30a7\u30fc\u30ba\u306b\u3042\u308b100\u4e07\u4eba\u4ee5\u4e0a\u306e\u60a3\u8005\u3092\u30b5\u30dd\u30fc\u30c8\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n","protected":false},"author":131,"featured_media":47218,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[322,341],"tags":[],"class_list":["post-47213","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-press-release","category-case-study"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/47213"}],"collection":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/comments?post=47213"}],"version-history":[{"count":7,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/47213\/revisions"}],"predecessor-version":[{"id":47264,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/47213\/revisions\/47264"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/media\/47218"}],"wp:attachment":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/media?parent=47213"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/categories?post=47213"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/tags?post=47213"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}